Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$9.22 - $15.02 $17,720 - $28,868
1,922 Added 14.54%
15,139 $158,000
Q4 2023

Feb 14, 2024

SELL
$6.5 - $12.85 $19,623 - $38,794
-3,019 Reduced 18.59%
13,217 $158,000
Q3 2023

Nov 13, 2023

BUY
$10.45 - $15.02 $40,608 - $58,367
3,886 Added 31.47%
16,236 $171,000
Q2 2023

Aug 11, 2023

SELL
$10.52 - $16.06 $29,403 - $44,887
-2,795 Reduced 18.45%
12,350 $166,000
Q1 2023

May 12, 2023

BUY
$7.32 - $14.38 $6,214 - $12,208
849 Added 5.94%
15,145 $215,000
Q4 2022

Feb 14, 2023

SELL
$7.19 - $13.16 $53,788 - $98,449
-7,481 Reduced 34.35%
14,296 $111,000
Q3 2022

Nov 10, 2022

BUY
$0.0 - $12.8 $0 - $278,745
21,777 New
21,777 $249,000

Others Institutions Holding ACCD

About Accolade, Inc.


  • Ticker ACCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 71,938,896
  • Market Cap $496M
  • Description
  • Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...
More about ACCD
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.